Alex Goldsmith - Profile and Investment Details

Investor Profile

Alex Goldsmith is a Venture Capital, Investor based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods, Inzen Therapeutics, Ohana Biosciences, T2 Biosystems, Tangent Medical Technologies, Kaleido BioSciences, Permeon Biologics, Kovio, Oasys Water, Editas Medicine, Tessera Therapeutics, Ring Therapeutics, Moderna Therapeutics, Omega Therapeutics, Cygnal Therapeutics, Sana Biotechnology, Seres Therapeutics, Agios Pharmaceuticals, Red Rock Biofuels, Tarveda Therapeutics, Receptos, Repertoire Immune Medicines, Generate Biomedicines, Codiak Biosciences, BlackDuck, Polatis, Seventh Sense Biosystems, Sigilon Therapeutics, Boragen, TARIS Biomedical, TransMedics, Selecta Biosciences, Quanterix, Visterra, Sesen Bio, Inc., CiBO Technologies, medidametrics, Rubius Therapeutics, Axcella, Senda Biosciences, Foghorn TherapeuticsEvelo Biosciences, Inari, Joule Unlimited Technologies, Cellarity, WikiCell Designs, Avedro, Indigo, EcoSense Lighting, Pfizer, Valo Health, Invaio Sciences, . Over time, Alex Goldsmith has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Alex Goldsmith is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Creative Venture, Clean Tech, Health Care, Research and Development, Regenerative Medicine, Drug Discovery, Wellness, Women Founded, Healthcare Innovation, Strategic Partnerships, Life Science, Engineering, Science, Venture Fundraising, Biotechnology, Medical Devices, Drug Development, Hispanic / Latinx Founded, Clean Technology, Entrepreneurship, Electronic Health Records (EHR), Health and Hospital Services, Innovation, Clinical Trials, Groceries, Disruptive technology, Research, Agriculture, Personalized Medicine, Oil and Gas, Renewable Energy, Medical, Information Technology, B2B, Therapeutics, Health Tech, Machine Learning, Personal Health, Pharmaceuticals may find it worthwhile to explore potential connections with Alex Goldsmith, as their portfolio suggests a familiarity and interest in this area.

Understanding Alex Goldsmith’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.